These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 262335)

  • 1. Factor XIII, fibrin and collagen.
    Duckert F; Nyman D
    Suppl Thromb Haemost; 1978; 63():391-6. PubMed ID: 262335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factor XIII, its physiological significance (a review of the literature)].
    Baluda VP; Zhukova NA
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843
    [No Abstract]   [Full Text] [Related]  

  • 3. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin sealants in supporting surgical techniques: strength in factor XIII.
    Phillips M; Dickneite G; Metzner H
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():13-6. PubMed ID: 12869983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological significance of the fibrin stabilizing factor (factor XIII)].
    Duckert F
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1342-7. PubMed ID: 4424195
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII deficiency: pathogenic mechanisms and clinical significance.
    Egbring R; Kröniger A; Seitz R
    Semin Thromb Hemost; 1996; 22(5):419-25. PubMed ID: 8989826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affects of F XIII in wound-healing--Fibrin stability in tissues and cross linking of angiogenesis modulator, osteonectin to fibrin.
    Chung SI; Lee SY; Ryogin U; Kamemitsu K
    Rinsho Byori; 1997 Feb; Suppl 104():50. PubMed ID: 9128364
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen matrix-bound clotting factors (CMBCF) promote healing-associated events independent of factor XIII in an in vitro model.
    Pohle T; Becker JC; Lügering A
    Wound Repair Regen; 2011 Nov; 19(6):687-92. PubMed ID: 22092839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
    Glover CJ; McIntire LV; Brown CH; Natelson EA
    J Lab Clin Med; 1975 Oct; 86(4):644-56. PubMed ID: 1176815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of coagulation factor XIII (FXIII) in angiogenesis and tissue repair.
    Inbal A; Dardik R
    Pathophysiol Haemost Thromb; 2006; 35(1-2):162-5. PubMed ID: 16855365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of alpha-polymers and residual alpha-chains in in vitro and in vivo formed fibrin clots.
    Barthels M; Förstermann U; Sosada M; Poliwoda H
    Behring Inst Mitt; 1986 Feb; (79):24-30. PubMed ID: 3718409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing fibrin glue performance as modulated by heparin, aprotinin, and factor XIII.
    Marx G; Mou X
    J Lab Clin Med; 2002 Sep; 140(3):152-60. PubMed ID: 12271272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet accumulation on fibrin-coated polyethylene: role of platelet activation and factor XIII.
    Rubens FD; Perry DW; Hatton MW; Bishop PD; Packham MA; Kinlough-Rathbone RL
    Thromb Haemost; 1995 May; 73(5):850-6. PubMed ID: 7482415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII deficiency.
    Hsieh L; Nugent D
    Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.